S P Balk - JoVE Visualize

Showing results (61-70 of 70) with videos related to

Pageof 7

Sort By:

You have reached the last page of results.This site can display upto 70 results.

Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 20, 2001

A multi-institutional phase ii study of SU101, a platelet-derived growth factor receptor inhibitor, for patients with hormone-refractory prostate cancerY J Ko, E J Small, F Kabbinavar, et al.

Journal of Immunology (Baltimore, Md. : 1950)|March 1, 1997

Nonclassical behavior of the mouse CD1 class I-like moleculeM Teitell, H R Holcombe, L Brossay, et al.

Journal of Immunology (Baltimore, Md. : 1950)|October 1, 1996

Persistent clonal expansions of peripheral blood CD4+ lymphocytes in chronic inflammatory bowel diseaseC S Probert, A Chott, J R Turner, et al.

Molecular Endocrinology (Baltimore, Md.)|May 1, 2001

Cyclin D1 binds the androgen receptor and regulates hormone-dependent signaling in a p300/CBP-associated factor (P/CAF)-dependent mannerA T Reutens, M Fu, C Wang, et al.

Science (New York, N.Y.)|March 21, 1998

Natural ligand of mouse CD1d1: cellular glycosylphosphatidylinositolS Joyce, A S Woods, J W Yewdell, et al.

Immunology|May 16, 2000

CD1d structure and regulation on human thymocytes, peripheral blood T cells, B cells and monocytesM Exley, J Garcia, S B Wilson, et al.

Journal of Leukocyte Biology|May 19, 2001

CD1d-reactive T-cell activation leads to amelioration of disease caused by diabetogenic encephalomyocarditis virusM A Exley, N J Bigley, O Cheng, et al.

Prostate Cancer and Prostatic Diseases|August 6, 2014

Imaging, procedural and clinical variables associated with tumor yield on bone biopsy in metastatic castration-resistant prostate cancerR R McKay, K A Zukotynski, L Werner, et al.

Nature|January 15, 1998

Extreme Th1 bias of invariant Valpha24JalphaQ T cells in type 1 diabetesS B Wilson, S C Kent, K T Patton, et al.

Gastroenterology|July 13, 2000

Activation of natural killer T cells by alpha-galactosylceramide in the presence of CD1d provides protection against colitis in miceL J Saubermann, P Beck, Y P De Jong, et al.

Pageof 7

Showing results (61-70 of 70) with videos related to

Sort By:

Pageof 7

You have reached the last page of results.This site can display upto 70 results.

Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 20, 2001

A multi-institutional phase ii study of SU101, a platelet-derived growth factor receptor inhibitor, for patients with hormone-refractory prostate cancerY J Ko, E J Small, F Kabbinavar, et al.

Journal of Immunology (Baltimore, Md. : 1950)|March 1, 1997

Nonclassical behavior of the mouse CD1 class I-like moleculeM Teitell, H R Holcombe, L Brossay, et al.

Journal of Immunology (Baltimore, Md. : 1950)|October 1, 1996

Persistent clonal expansions of peripheral blood CD4+ lymphocytes in chronic inflammatory bowel diseaseC S Probert, A Chott, J R Turner, et al.

Molecular Endocrinology (Baltimore, Md.)|May 1, 2001

Cyclin D1 binds the androgen receptor and regulates hormone-dependent signaling in a p300/CBP-associated factor (P/CAF)-dependent mannerA T Reutens, M Fu, C Wang, et al.

Science (New York, N.Y.)|March 21, 1998

Natural ligand of mouse CD1d1: cellular glycosylphosphatidylinositolS Joyce, A S Woods, J W Yewdell, et al.

Immunology|May 16, 2000

CD1d structure and regulation on human thymocytes, peripheral blood T cells, B cells and monocytesM Exley, J Garcia, S B Wilson, et al.

Journal of Leukocyte Biology|May 19, 2001

CD1d-reactive T-cell activation leads to amelioration of disease caused by diabetogenic encephalomyocarditis virusM A Exley, N J Bigley, O Cheng, et al.

Prostate Cancer and Prostatic Diseases|August 6, 2014

Imaging, procedural and clinical variables associated with tumor yield on bone biopsy in metastatic castration-resistant prostate cancerR R McKay, K A Zukotynski, L Werner, et al.

Nature|January 15, 1998

Extreme Th1 bias of invariant Valpha24JalphaQ T cells in type 1 diabetesS B Wilson, S C Kent, K T Patton, et al.

Gastroenterology|July 13, 2000

Activation of natural killer T cells by alpha-galactosylceramide in the presence of CD1d provides protection against colitis in miceL J Saubermann, P Beck, Y P De Jong, et al.

Pageof 7